Pillstats
Rx only · Solution · Ophthalmic

Dorzolamide Hydrochloride And Timolol Maleate

Dorzolamide Hydrochloride + Timolol Maleate

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers4 labelers
Packages5
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.271$0.543$0.814$1.09Dec 2025Mar 2026Jun 2026
$0.916
Latest avg · Jun 17, 2026
-3%
Since Dec 17, 2025
4
Active US suppliers
60%
Top-2 supplier share*

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Sandoz Incunknown2SUPPLYING
Bryant Ranch Prepackrepackager1SUPPLYING
Genus Lifesciencesunknown1SUPPLYING
Somerset Therapeutics, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.